Company News: Page (1) of 1 - 05/31/14

PROCLAIM(SM) National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treated with High-Dose Interleukin-2 (HD IL-2)

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option

May 31, 2014 --
Our Apologies, This article is no longer available, You may have followed an outdated link.

Page: 1
Related Keywords:Pro AV, Post/Production, Presentors, Director, Business, Marketing, Standards/Initiatives, OS (Operating System), Inc., Medicine, Disease, healthcare, Cancer, Surgery, Medication, Vitamins/Nutrition, Physician, Science, Lifestyle, Medical, Biology, Cancer, Business, Science, Adults,

Source:PR Newswire. All Rights Reserved

@ Copyright, 2014 Digital Media Online, All Rights Reserved

Digital Media Online, Inc.